The future for injectable contraceptives.
D000349:Africa; D017954:Africa South of the Sahara; D000351:Africa, Eastern; D001723:Birth Rate; D003267:Contraception; D003268:Contraception Behavior; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003710:Demography; D003906:Developing Countries; D005193:Family Planning Services; D005298:Fertility; D007267:Injections; D007390:International Agencies; D007630:Kenya; D017258:Medroxyprogesterone Acetate; D009640:Norethindrone; D009938:Organizations; D011153:Population; D011157:Population Dynamics
D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D017258:Medroxyprogesterone Acetate; D009640:Norethindrone
Africa; Africa South Of The Sahara; Birth Rate; Contraception; Contraceptive Agents, Female--side effects; Contraceptive Agents, Progestin--side effects; Contraceptive Agents--side effects; Contraceptive Implants; Contraceptive Methods; Contraceptive Prevalence; Contraceptive Usage; Demographic Factors; Depo-provera--side effects; Developing Countries; Eastern Africa; English Speaking Africa; Family Planning; Fertility; Fertility Decline; Fertility Measurements; Fertility Rate; Injectables; International Agencies; Kenya; Medroxyprogesterone Acetate--side effects; Norethindrone; Norethindrone Enanthate; Organizations; Population; Population Dynamics; Total Fertility Rate